Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys

Journal of Infectious Diseases

Volumn 185, Issue 5, 2002, Pages 657-664

  Hisaeda, Hajime ^a,b   Saul, Allan ^a   Reece, Joshua J ^a   Kennedy, Michael C ^a   Long, Carole A ^a   Miller, Louis H ^a   Stowers, Anthony W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; MALARIA VACCINE; MEFLOQUINE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 3; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; MALARIA CONTROL; MALARIA FALCIPARUM; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROVOCATION TEST; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, BACTERIAL; AOTIDAE; BACTERIAL PROTEINS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; SACCHAROMYCES CEREVISIAE; VACCINATION; VACCINES, SYNTHETIC;

EID: 0036498871     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/339187     Document Type: Article

References (36)

1. Pathways and strategies for developing a malaria blood-stage vaccine
2. Antibodies and Plasmodium falciparum merozoites
3. Merozoite surface protein-3: A malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes
4. Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites
5. Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain
6. Plasmodium vivax merozoite surface proteins-3β and -3γ share structural similarities with P. vivax merozoite surface protein-3α and define a new gene family
7. The malaria merozoite surface: A 140,000 m.w. protein antigenically unrelated to other surface components on Plasmodium knowlesi merozoites
8. Molecular basis for mutation in a surface protein expressed by malaria parasites
9. Allelic lineages of the merozoite surface protein 3 gene in Plasmodium reichenowi and Plasmodium falciparum
10. The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex
11. Solution structure of a polypeptide containing four heptad repeat units from a merozoite surface antigen of Plasmodium falciparum
12. Analysis of compositionally biased regions in sequence databases
13. A region of Plasmodium falciparum antigen pfs25 that is the target of highly potent transmission-blocking
14. Efficacy in an Aotus challenge trial of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1
15. Antibodies to malaria vaccine candidates pvs25 and pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes
16. Are trials in New World monkeys on the critical path for blood-stage malaria vaccine development?
17. Human malaria parasites in continuous culture
18. Induction of protective immunity against experimental infection with malaria using synthetic peptides
19. Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins
20. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria
21. Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites
22. Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys
23. Conservation of structural motifs and antigenic diversity in the Plasmodium falciparum merozoite surface protein-3 (MSP-3)
24. Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum
25. Human malaria in immunocompromised mice: An in vivo model to study defense mechanisms against Plasmodium falciparum
26. Monoclonal antibodies to a 140,000-m.w. protein on Plasmodium knowlesi merozoites inhibit their invasion of rhesus erythrocytes
27. Vaccination-induced variation in the 140 kD merozoite surface antigen of Plasmodium knowlesi malaria
28. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model
29. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors
30. Crossreactive antigens between life cycle stages of Plasmodium falciparum
31. Two immunogenic peptide conjugates derived from P. falciparum MSA2 give rise to antibodies that cross-react with a nonhomologous 195-kDa malarial protein
32. A peptide derived from a B cell epitope of Plasmodium falciparum rhoptry associated protein 2 specifically raises antibodies to rhoptry associated protein 1
33. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys
34. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen
35. Repeated infection of Aotus monkeys with Plasmodium falciparum induces protection against subsequent challenge with homologous and beterologous strains of parasite
36. Identification of mechanisms of defense prevailing in humans as a rationale for vaccine development